BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang H, Chen XP, Qiu FZ. Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma. World J Gastroenterol 2004; 10(9): 1281-1285 [PMID: 15112342 DOI: 10.3748/wjg.v10.i9.1281]
URL: https://www.wjgnet.com/1007-9327/full/v10/i9/1281.htm
Number Citing Articles
1
Seigo Kinuya, Jingming Bai, Kazuhiro Shiba, Kunihiko Yokoyama, Hirofumi Mori, Makoto Fukuoka, Naoto Watanabe, Noriyuki Shuke, Takatoshi Michigishi, Norihisa Tonami. 99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cellsAnnals of Nuclear Medicine 2006; 20(1): 29 doi: 10.1007/BF02985587
2
Ana F. Brito, Mónica Mendes, Ana M. Abrantes, José G. Tralhão, Maria F. Botelho. Positron Emission Tomography Diagnostic Imaging in Multidrug-Resistant Hepatocellular Carcinoma: Focus on 2-Deoxy-2-(18F)Fluoro-d-GlucoseMolecular Diagnosis & Therapy 2014; 18(5): 495 doi: 10.1007/s40291-014-0106-3
3
Wouter B. Nagengast, Thijs H. Oude Munnink, Eli C. F. Dijkers, Geke A. P. Hospers, Adrienne H. Brouwers, Carolien P. Schröder, Marjolijn Lub-de Hooge, Elisabeth G. E. de Vries. Multi-Drug Resistance in CancerMethods in Molecular Biology 2010; 596: 15 doi: 10.1007/978-1-60761-416-6_2
4
Ekaterina Tiktinsky, Tifha Horne, Svetlana Agranovich, Sophie Lantsberg. Tc-99m methoxyisobutylisonitrile parathyroid scintigraphyNuclear Medicine Communications 2011; 32(11): 1079 doi: 10.1097/MNM.0b013e32834b636c
5
Ulrike S. Stein, Wolfgang Walther, Peter M. Schlag. Regional Cancer TherapyCancer Drug Discovery and Development 2007; : 3 doi: 10.1007/978-1-59745-225-0_1
6
Sabina Dizdarevic, Adrien Michael Peters. Resistance to Targeted ABC Transporters in CancerResistance to Targeted Anti-Cancer Therapeutics 2015; 4: 133 doi: 10.1007/978-3-319-09801-2_6
7
J.E. Manautou, C.I. Ghanem. Comprehensive Toxicology2018; : 215 doi: 10.1016/B978-0-12-801238-3.95661-7
8
J.E. Manautou, S.N. Campion, L.M. Aleksunes. Comprehensive Toxicology2010; : 175 doi: 10.1016/B978-0-08-046884-6.01008-3
9
Wolfgang Löscher, Heidrun Potschka. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseasesProgress in Neurobiology 2005; 76(1): 22 doi: 10.1016/j.pneurobio.2005.04.006
10
Ulrike Stein, Wolfgang Walther. Reversal of ABC Transporter-Dependent Multidrug Resistance in CancerAmerican Journal of Cancer 2006; 5(5): 285 doi: 10.2165/00024669-200605050-00001
11
Münir DEMİRCİ. THE ROLE OF Tc-99m MIBI SPECT IN THE EVALUATION OF NON-SMALL CELL LUNG TUMORSAtatürk Üniversitesi Tıp Fakültesi Cerrahi Tıp Bilimleri Dergisi 2023; 2(3): 100 doi: 10.61745/jsmsau.1281557
12
Xiao-Yi Duan, Jian-Sheng Wang, Min Liu, You-Min Guo. Technetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancerAnnals of Nuclear Medicine 2008; 22(1): 49 doi: 10.1007/s12149-007-0080-5
13
Zachary Miklja, Viveka Nand Yadav, Rodrigo T. Cartaxo, Ruby Siada, Chase C. Thomas, Jessica R. Cummings, Brendan Mullan, Stefanie Stallard, Alyssa Paul, Amy K. Bruzek, Kyle Wierzbicki, Tao Yang, Taylor Garcia, Ian Wolfe, Marcia Leonard, Patricia L. Robertson, Hugh J.L. Garton, Daniel R. Wahl, Hemant Parmar, Jann N. Sarkaria, Cassie Kline, Sabine Mueller, Theodore Nicolaides, Chana Glasser, Sarah E.S. Leary, Sriram Venneti, Chandan Kumar-Sinha, Arul M. Chinnaiyan, Rajen Mody, Manjunath P. Pai, Timothy N. Phoenix, Bernard L. Marini, Carl Koschmann. Everolimus improves the efficacy of dasatinib in PDGFRα-driven gliomaJournal of Clinical Investigation 2020; 130(10): 5313 doi: 10.1172/JCI133310
14
Susan E. Bates, John Deeken, Chaohong Fan, Robert W. Robey. Cancer Drug ResistanceCancer Drug Discovery and Development 2006; : 261 doi: 10.1007/978-1-59745-035-5_15